Tracking progress on antimicrobial resistance by the quadripartite country self-assessment survey (TrACSS) in G7 countries, 2017–2023: opportunities and gaps

• Published in: Pharmacological research 2024-06, Vol.204, p.107188, Article 107188
• Main Authors: Sabbatucci, Michela, Ashiru-Oredope, Diane, Barbier, Laura, Bohin, Elisa, Bou-Antoun, Sabine, Brown, Colin, Clarici, Alexandra, Fuentes, Claire, Goto, Takahiro, Maraglino, Francesco, Morin, Julien, Rönnefahrt, Ines, Sanwidi, Andrea, Triggs-Hodge, Carry, Vitiello, Antonio, Zovi, Andrea, Gelormini, Marcello, Lo Fo Wong, Danilo
• Format: Article
• Language: English
• Subjects: Animals; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; antibiotics; Antimicrobial resistance; Drug Resistance, Bacterial; Global Health; Humans; Self-Assessment; Surveys and Questionnaires; Tracking AMR country self-assessment survey; TrACSS; World Health Organization
• ISSN: 1043-6618; 1096-1186; 1096-1186
• DOI: 10.1016/j.phrs.2024.107188

Antimicrobial resistance (AMR) poses serious challenges to the healthcare systems worldwide. Multiple factors and activities contribute to the development and spread of antimicrobial-resistant microorganisms. Monitoring progress in combating AMR is fundamental at both global and national levels to drive multisectoral actions, identify priorities, and coordinate strategies. Since 2017, the World Health Organization (WHO) has collected data through the Tracking AMR Country Self-Assessment Survey (TrACSS). TrACSS data are published in a publicly-available database. In 2023, 71 (59.9%) out of 177 responding countries reported the existence of a monitoring and evaluation plan for their National Action Plan (NAP) on AMR, and just 20 countries (11.3%) the allocation of funding to support NAP implementation. Countries reported challenges including limited financial and human resources, lack of technical capacity, and variable political commitment. Even across the Group of Seven (G7) countries, which represent some of the world's most advanced economies, many areas still need improvement, such as full implementation of infection prevention and control measures, adoption of WHO access/watch/reserve (AWaRe) classification of antibiotics, effective integration of laboratories in AMR surveillance in the animal health and food safety sectors, training and education, good manufacturing and hygiene practices in food processing, optimising pesticides use and environmental residues of antimicrobial drugs. Continuous and coordinated efforts are needed to strengthen multisectoral engagement to fight AMR. [Display omitted]